Abstract
Various members of the fibroblast growth factor (FGF) family mitigate radiation-induced damage. We designed and synthesized the binding domain peptide of FGF-2 (FGF-P) with a dimer form resistant to peptidase and examined its mitigatory effect on murine bone marrow cells. NIH Swiss mice were exposed to different doses of total body irradiation (TBI) and treated with ten doses of 5 mg/kg FGF-P. We achieved the following results: (1) FGF-P stimulated the growth of bone marrow cells harvested from mice exposed to 3 Gy; (2) on day 25 after 6 Gy TBI, the number of leukocytes and granulocytes was higher in the FGF-P group than in the vehicle-alone group; (3) FGF-P significantly increased the number of pro-B and pre-B cells; and (4) FGF-P treatment in vivo increased the long-term hematopoietic stem cells (LT-HSC) in bone marrow. These data reveal the underlying mechanism by which FGF-P rescued a significant percentage of the exposed mice. The increase of LT-HSC in bone marrow leads to a concomitant increase of pro-B and pre-B cells followed by leukocytes and granulocytes, which in turn enhance immunity against infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Herodin F, Grenier N, Drouet M (2007) Revisiting therapeutic strategies in radiation casualties. Exp Hematol 35:28–33
TMT handbook. http://www.tmthandbook.org/. 18 Jul 2011
Layton JE, Hall NE, Connell F et al (2001) Identification of ligand-binding site III on the immunoglobulin-like domain of the granulocyte colony-stimulating factor receptor. J Biol Chem 276:36779–36787
Lin X, Takahashi K, Campion SL et al (2006) Synthetic peptide F2A4-K-NS mimics fibroblast growth factor-2 in vitro and is angiogenic in vivo. Int J Mol Med 17:833–839
Acknowledgments
This project is supported in part by U19 AI067733, RC1AI078519, RC2-AI-087580, RC1-AI081274 (NIAID/NIH), and Shands Cancer Center startup funds (University of Florida). We thank Dr. Chihray Liu and the medical physics faculty at UF for ensuring dosimetric accuracy in these experiments and Kate Casey-Sawicki for editing this manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this paper
Cite this paper
Ma, J. et al. (2013). Fibroblast Growth Factor-Peptide Promotes Bone Marrow Recovery After Irradiation. In: Welch, W.J., Palm, F., Bruley, D.F., Harrison, D.K. (eds) Oxygen Transport to Tissue XXXIV. Advances in Experimental Medicine and Biology, vol 765. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4989-8_22
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4989-8_22
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4771-9
Online ISBN: 978-1-4614-4989-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)